An interventional study of Ciprofol and Propofol in Hypotension, sponsored by General Hospital of Ningxia Medical University. Not yet recruiting at 1 site in China. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-06-23.
Sponsored by General Hospital of Ningxia Medical University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Hypotension with a site in China — 26 open to participants now, 29 under way, none of them phase 3. Hypotension · China.
Among the 59 studies in Hypotension with a site in China, this one is the 27th largest by planned enrollment of the 40 interventional ones that give a count, is one of 11 that started in 2026, is one of 26 with no phase, reaches primary completion later than 15 of the 28 other live ones, and was the 54th registered.
892 studies on the registry are indexed under Hypotension; 199 are open to participants now.
Browse Hypotension studies →26 of the 59 studies in Hypotension with a site in China are open now. Recruiting first, the newest first:
Beijing Tsinghua Chang Gung Hospital · Sites in China
Ages 18–85
Peking Union Medical College Hospital · Sites in China
Ages 65+
Peking Union Medical College Hospital · Sites in China
Ages 65+
Sixth Affiliated Hospital, Sun Yat-sen University · Sites in China
Ages 65+
Nanfang Hospital, Southern Medical University · Sites in China
Ages 65–90
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.
This study: 60 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 5 · Phase 4 9
First in 2013; this study’s year is marked. 11 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 96 is above the median of 86 across 593 interventional studies indexed under Hypotension.
Median enrollment 129 across the 40 interventional studies, 200 across the 19 observational. Of the 20 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 59 has an industry lead sponsor. The 10 most frequent:
General Hospital of Ningxia Medical University is the lead sponsor of 111 studies on the registry; 44 are open to participants now.
General Hospital of Ningxia Medical University has 6 studies filed under Hypotension — fewer than ten, so there is no comparison to draw.
11 of the studies in Hypotension with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07328958Sixth Affiliated Hospital, Sun Yat-sen UniversityEffect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial | 2026-12-30 |
| NCT07663695General Hospital of Ningxia Medical UniversityPropofol vs. Ciprofol for Anesthesia Induction in Frail Elderly Patients | 2026-12-31 |
| NCT07156474Lanyue ZhuImpact of Intraoperative Blood Pressure Components on Postoperative AKI: A Phenotype-Stratified Analysis | 2026-12-31 |
| NCT07239492Xuanwu Hospital, BeijingEfficacy and Safety Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Regulation | 2027-01-01 |
| NCT07949825The Fourth Affiliated Hospital of Zhejiang University School of MedicineEffect of Carotid Corrected Flow Time Guided Fluid Management on Post-Induction Hypotension in Elderly Patients | 2027-01-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 59 studies in Hypotension with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Post-induction hypotension (PIH) is a common and critical complication during general anesthesia, particularly in frail elderly patients whose physiological reserves are significantly diminished. PIH is strongly associated with adverse postoperative outcomes, including acute kidney injury (AKI) and myocardial injury. Propofol is the most widely used induction agent but frequently induces circulatory depression. Ciprofol, a novel anesthetic agent developed by optimizing the molecular structure of propofol, has demonstrated improved hemodynamic stability and fewer adverse effects in general populations. However, its specific impact on frail elderly patients remains unestablished.
The primary purpose of this single-center, randomized, double-blind, controlled trial is to compare the effects of propofol and ciprofol during anesthesia induction on the incidence of PIH in frail elderly patients undergoing major abdominal surgery. The investigator's hypothesis is that ciprofol will significantly lower the incidence of PIH compared to propofol. Additionally, the study will evaluate secondary clinical outcomes, such as postoperative AKI, postoperative cardiac complications, and the overall quality of recovery, to provide an evidence-based clinical guide for selecting optimal induction agents for this vulnerable patient population.
Background and Rationale:
Frail elderly patients exhibit an accumulation of multi-system physiological decline, making them highly vulnerable to surgical and anesthetic stressors. During the induction of general anesthesia, these patients are at an exceptionally high risk for severe and prolonged hypotension due to reduced cardiac stroke volume, impaired autonomic nervous system regulation, and altered pharmacokinetics. Post-induction hypotension (PIH)-occurring from the initiation of anesthesia to 10 minutes post-intubation-is directly influenced by the choice of induction agent and the patient's baseline condition, with fewer confounding factors than intraoperative hypotension.
While propofol is highly efficient, its prominent side effect is cardiovascular depression. Ciprofol is an innovative 2,6-disubstituted phenol derivative that maintains the rapid onset and recovery advantages of propofol while offering enhanced hemodynamic stability. To date, clinical evidence comparing these two agents specifically in the frail elderly population is lacking. This study seeks to evaluate whether ciprofol can mitigate the risk of PIH in frail elderly patients undergoing major abdominal surgery and to observe its downstream impacts on major organ protection and postoperative recovery quality.
Study Workflow and Anesthesia Management:
Intervention:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
The top of the normal range for a blood test, as set by the laboratory that runs it. Each lab prints its own range next to your result.
“≤ 2.5 × ULN” means the result can be up to two and a half times that top value.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ULN (upper limit of normal)
The top of the normal range for a blood test, as set by the laboratory that runs it. Each lab prints its own range next to your result.
“≤ 2.5 × ULN” means the result can be up to two and a half times that top value.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Frail elderly patients undergoing major abdominal surgery who receive ciprofol for general anesthesia induction, combined with midazolam, sufentanil, and rocuronium.
Drug: Ciprofol
Frail elderly patients undergoing major abdominal surgery who receive propofol for general anesthesia induction, combined with midazolam, sufentanil, and rocuronium.
Drug: Propofol
Incidence of post-induction hypotension (PIH)
Post-induction hypotension (PIH) is defined as a mean arterial pressure (MAP) \< 65 mmHg lasting for more than 1 minute.
Time frame: From the initiation of general anesthesia drug administration until 10 minutes after endotracheal intubation.
Start is estimated for Jun 2026; primary completion for Dec 2026, 6 months later.
Of 213 non-industry interventional studies with no phase under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 6 months is below that.
Counting every sponsor, half of 220 studies reached it within 12 months; a quarter within 6 and three quarters within 22.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ciprofol
General Hospital of Ningxia Medical University →